Covetrus Announces Real-Time Integration of Its Prescription Management Platform for eVetPractice® Users
Summary
This integration represents a major step forward as Covetrus brings to market a cohesive set of technology services focused on improving workflow and efficiency in the veterinary practice with prescription management and compliance at the center. “ We’re very pleased to offer practices that use AVImark, ImproMed, and, now, eVetPractice an unparalleled level of integration with our prescription management technology,” said Chris Dollar, senior vice president of Covetrus Global Software Services. Streamlining this workflow through the tighter integration with the practice management system can help eliminate administrative burden, drive greater client engagement and improve health and financial outcomes. This press release contains certain statements that are forward-looking within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and that involve risks and uncertainties, including statements about our future financial and operating results, plans, objectives, expenses, expectations, intentions, trends in our business, our liquidity, product development and improvements, and other matters. Such statements are subject to numerous risks and uncertainties, including but not limited to, risks associated with the ability to successfully integrate operations and employees; the ability to realize anticipated benefits and synergies of the transaction that created Covetrus; the potential impact of the consummation of the transaction on relationships, including with employees, customers and competitors; the ability to retain key personnel; the ability to achieve performance targets; changes in financial markets, interest rates and foreign currency exchange rates, and those additional risks and factors discussed in our Annual Report on Form 10-K filed on March 29, 2019 and Quarterly Report on Form 10-Q filed for the quarter ended March 31, 2019, including those discussed under the heading “Risk Factors.” Our forward-looking statements are based on current beliefs and expectations of our management team and, except as required by law, we undertake no obligations to make any revisions to the forward-looking statements contained in this release or to update them to reflect events or circumstances occurring after the date of this release, whether as a result of new information, future developments or otherwise.